These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7562949)

  • 1. Development of a potent thrombin receptor ligand.
    Feng DM; Veber DF; Connolly TM; Condra C; Tang MJ; Nutt RF
    J Med Chem; 1995 Sep; 38(20):4125-30. PubMed ID: 7562949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation.
    Shimohigashi Y; Nose T; Okazaki M; Satoh Y; Ohno M; Costa T; Shimizu N; Ogino Y
    Biochem Biophys Res Commun; 1994 Aug; 203(1):366-72. PubMed ID: 8074680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes.
    Debeir T; Vigé X; Benavides J
    Eur J Pharmacol; 1997 Mar; 323(1):111-7. PubMed ID: 9105886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human class 1 heparin-binding growth factor: structure and homology to bovine acidic brain fibroblast growth factor.
    Harper JW; Strydom DJ; Lobb RR
    Biochemistry; 1986 Jul; 25(14):4097-103. PubMed ID: 2427112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
    Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
    Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence of bovine brain derived class 1 heparin-binding growth factor.
    Strydom DJ; Harper JW; Lobb RR
    Biochemistry; 1986 Mar; 25(5):945-51. PubMed ID: 2421762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the thrombin receptor of human glomerular mesangial cells by Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe peptide.
    Troyer D; Padilla R; Smith T; Kreisberg J; Glass W
    J Biol Chem; 1992 Oct; 267(28):20126-31. PubMed ID: 1328194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
    Natarajan S; Riexinger D; Peluso M; Seiler SM
    Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid sequence of bovine angiogenin.
    Bond MD; Strydom DJ
    Biochemistry; 1989 Jul; 28(14):6110-3. PubMed ID: 2775757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.